Search

Becton Dickinson and Co

Open

SectorHealthcare

199.12 0.76

Overview

Share price change

24h

Current

Min

196.93

Max

198.45

Key metrics

By Trading Economics

Income

759M

449M

Sales

269M

5B

P/E

Sector Avg

46.209

50.373

EPS

3.23

Dividend yield

2.11

Profit margin

9.011

Employees

72,000

EBITDA

540M

1.2B

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-3.07% downside

Dividends

By Acuity

Dividend yield

Sector Avg

2.11%

2.12%

Next Earnings

5 lis 2026

Next Dividend date

30 gru 2026

Next Ex Dividend date

7 gru 2026

Market Stats

By TradingEconomics

Market Cap

7.9B

53B

Previous open

198.36

Previous close

199.12

Becton Dickinson and Co Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

31 paź 2026, 00:01 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reaching its highest level of the day and well above its 20-day moving average.

30 paź 2026, 21:51 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, continuing a strong performance that began shortly after the market closed.

29 paź 2026, 23:01 UTC

Becton Dickinson and Co shares are lower in after-market hours, reflecting broader market declines despite stronger-than-expected Q3 GDP growth.

28 paź 2026, 20:13 UTC

Becton Dickinson and Co shares advanced modestly in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

27 paź 2026, 19:16 UTC

Becton Dickinson and Co shares are declining, marking three consecutive lower daily closes, despite earlier rebounding from a session low.

26 paź 2026, 20:13 UTC

Becton Dickinson and Co's shares traded modestly lower during after-market hours on Monday, following a period of relative stability since the market closed.

24 paź 2026, 00:02 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

23 paź 2026, 23:21 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month trading range.

22 paź 2026, 23:01 UTC

Becton Dickinson and Co shares fell in after-market trading, now at their lowest point of the day, moving lower since Thursday's close.

21 paź 2026, 19:56 UTC

Becton Dickinson and Co is experiencing a modest increase, currently positioned above its 20-day moving average and near the upper end of its one-month range.

20 paź 2026, 23:21 UTC

Correlated Moves

Becton Dickinson shares declined in after-market hours, influenced by disappointing earnings from holdings like Intuitive Surgical and Abbott Laboratories, amid broader sector weakness.

19 paź 2026, 22:21 UTC

Becton Dickinson and Co's shares rose in after-market trading, closing near session highs and reflecting a cumulative gain since Monday's close.

17 paź 2026, 00:01 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading following a drop shortly after Friday's close.

16 paź 2026, 23:11 UTC

Becton Dickinson and Co shares are modestly lower in after-market trading, continuing a gradual decline from Friday's close while remaining above the 20-day moving average.

15 paź 2026, 20:02 UTC

Becton Dickinson and Co's shares are advancing amid significant gains in the Health Care Equipment sub-sector, remaining well above their 20-day moving average.

14 paź 2026, 23:51 UTC

Becton Dickinson shares are lower in after-market trading, reflecting a broader market decline amid renewed losses in semiconductor stocks and rising inflation concerns.

13 paź 2026, 19:46 UTC

Becton Dickinson and Co shares fell modestly after an early peak, reflecting typical performance for this time of day, while remaining above the 20-day moving average.

12 paź 2026, 22:01 UTC

Becton Dickinson and Co. shares declined modestly during after-market hours, continuing earlier losses amid unusual volatility and fluctuations in trading activity.

8 paź 2026, 20:01 UTC

News

Becton Dickinson advocates for reducing maternal mortality rates at the UN General Assembly, emphasizing advanced monitoring technologies for childbirth complications.

7 paź 2026, 19:50 UTC

News

Becton Dickinson shares fell sharply after Barclays initiated coverage with an Underweight rating and set a price target of $165, overshadowing positive trial results.

6 paź 2026, 21:51 UTC

News

Becton Dickinson and Co shares declined in after-market trading after Barclays initiated coverage with an Underweight rating and a $165.00 price target.

5 paź 2026, 20:31 UTC

Becton Dickinson and Co is experiencing a deeper decline in after-market trading, now modestly lower since Monday's close and near the lower end of its one-month range.

2 paź 2026, 19:26 UTC

Becton Dickinson and Co shares fell, continuing a trend of weaker closes over the past four sessions, remaining significantly below their 20-day moving average.

1 paź 2026, 20:07 UTC

Becton Dickinson and Co's shares fell, marking a fourth consecutive day of declines, closing below Wednesday's level and its 20-day moving average.

30 wrz 2026, 20:20 UTC

Becton Dickinson and Co is trading modestly lower in after-market hours, continuing a decline below its recent trend and significantly under its 20-day moving average.

29 wrz 2026, 20:07 UTC

Becton Dickinson and Co's shares are declining, reflecting a broader market trend, despite an earlier rebound from a session low.

28 wrz 2026, 19:15 UTC

Becton Dickinson and Co shares fell slightly, trading around the midpoint of their one-month range after fluctuating earlier in the session.

25 wrz 2026, 22:55 UTC

Becton Dickinson and Co is trading modestly higher in after-market hours, reflecting upward movement from Friday's close, amid flat U.S. durable goods orders for August.

24 wrz 2026, 19:06 UTC

Becton Dickinson and Co shares fell sharply, reversing from an earlier peak and currently near the low end of their one-month range.

22 wrz 2026, 20:07 UTC

Becton Dickinson and Co is advancing, having gained ground since Monday's close, despite pulling back slightly from an earlier session peak.

Peer Comparison

Price change

Becton Dickinson and Co Forecast

Price Target

By TipRanks

-3.07% downside

12 Months Forecast

Average 191.8 USD  -3.07%

High 210 USD

Low 165 USD

Based on 10 Wall Street analysts offering 12 month price targets forBecton Dickinson and Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

4

Buy

5

Hold

1

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
help-icon Live chat